Clinical Trial Update: Efficacy and Safety of Zoledronic Acid in the Treatment of Bone Metastases-related Pain in Patients With Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of zoledronic acid for bone metastases-related pain in patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Prostate Cancer

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Pain | Phase 3 | Status: COMPLETED